Login / Signup

Topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in Nepal: rationale and design of a randomised controlled non-inferiority trial.

Jeremy John HoffmanReena YadavSandip Das SanyamPankaj ChaudharyAbhishek RoshanSanjay Kumar SinghSimon ArungaEinoti MatayanDavid MacleodHelen Anne WeissAstrid LeckVictor HuMatthew J Burton
Published in: BMJ open (2020)
ISRCTN14332621; pre-results.
Keyphrases
  • study protocol
  • wound healing
  • clinical trial
  • phase iii
  • randomized controlled trial
  • phase ii
  • tertiary care
  • open label
  • cell wall